Moreover, we provide evidence that the implementation of a panel of NCI-H295R, SJ-ACC3 and MUC-1 might be helpful for a more successful clinical translation of novel therapeutic regimens for ACC in the future. Here, MUC1 is linked to adrenal cortex carcinoma.